<unk>  is found in high levels in joints with rheumatoid arthritis and blocking<unk>  as a biological target may reduce the inflammation or damage. Some drugs (e.g. otilimab) are being developed to block<unk> . In critically ill patients<unk>  has been trialled as a therapy for the immunosuppression of critical illness, and has shown promise restoring monocyte and neutrophil function, although the impact on patient outcomes is currently unclear and awaits larger studies.<unk>  stimulates monocytes and<unk> s to produce pro-inflammatory cytokines, including CCL17. Elevated<unk>  has been shown to contribute to inflammation in inflammatory arthritis, osteoarthritis, colitis asthma, obesity, and COVID-19.
Granulocyte-macrophage colony-stimulating factor
Granulocyte colony-stimulating factor
Macrophage colony-stimulating factor
Hemopoietic growth factor
Erythropoietin
Colony-stimulating factor
Leukemia inhibitory factor
Thymic stromal lymphopoietin